Clinical Trials for Prognostic Stage IIIB Breast Cancer AJCC v8

Find clinical trials for prognostic stage iiib breast cancer ajcc v8. Discover research opportunities and treatment options in your area.

14 Active Trials Found

Showing 14 trials on this page

Page 1 of 1

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

NCT ID: NCT05455658

This clinical trial is studying a new treatment called STEMVAC for patients with early-stage triple-negative breast cancer, which is a type of breast cancer that does not express certain hormone re...

Recruiting

Phase: PHASE2 Type: interventional Locations: Baltimore, Maryland, United States, Seattle, Washington, United States +1 more

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

NCT ID: NCT06324240

This clinical trial is studying a new treatment approach for triple-negative breast cancer, a type of breast cancer that does not have specific receptors known to fuel most breast cancer growth. Th...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Atlanta, Georgia, United States, Atlanta, Georgia, United States +2 more

A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment

NCT ID: NCT05243056

This clinical trial, called Y-AMBIENT, is focused on helping young African American women who are dealing with stage I-III breast cancer. The goal is to improve their quality of life through a spec...

Recruiting

Phase: NA Type: interventional Locations: Columbus, Ohio, United States

Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study

NCT ID: NCT04754412

This clinical trial, called the Writing to Heal Study, is exploring how a special writing program can help improve the health of Chinese immigrant women who have survived breast cancer. The program...

Recruiting

Phase: NA Type: interventional Locations: Houston, Texas, United States

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

NCT ID: NCT02918474

This clinical trial is exploring a decision-making tool designed to help women with newly diagnosed breast cancer understand their surgical options, particularly regarding contralateral prophylacti...

Recruiting

Phase: NA Type: interventional Locations: Houston, Texas, United States

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

NCT ID: NCT05319873

This clinical trial is investigating a combination of three medications—ribociclib, tucatinib, and trastuzumab—for treating HER2 positive breast cancer, which is a type of breast cancer that can gr...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States

Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer

NCT ID: NCT05368428

This clinical trial is studying a treatment called Transcutaneous Electrical Nerve Stimulation (TENS) for patients with early-stage breast cancer who are experiencing nerve pain due to chemotherapy...

Recruiting

Phase: NA Type: interventional Locations: Atlanta, Georgia, United States, Atlanta, Georgia, United States +1 more

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

NCT ID: NCT05417308

This clinical trial is exploring whether topical (applied to the skin) or oral (taken by mouth) minoxidil can help women with breast cancer who are experiencing hair loss due to endocrine therapy. ...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Columbus, Ohio, United States

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

NCT ID: NCT05092373

This clinical trial is studying a new treatment approach for patients with advanced solid tumors affecting the abdomen or chest, such as advanced breast, ovarian, or liver cancer. The researchers a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors

NCT ID: NCT05452681

This clinical trial is designed to help young African American women who have survived breast cancer. It focuses on improving their quality of life (QoL) after they have finished their treatment, w...

Recruiting

Phase: NA Type: interventional Locations: Columbus, Ohio, United States

Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer

NCT ID: NCT04090567

This clinical trial is exploring the effectiveness of two medications, olaparib combined with either cediranib or AZD6738, in treating advanced breast cancer that has a specific genetic mutation kn...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

NCT ID: NCT04329065

This clinical trial is exploring a new treatment approach for patients with breast cancer by combining a vaccine called WOKVAC with chemotherapy and targeted therapy before surgery. The WOKVAC vacc...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

NCT ID: NCT03979508

This clinical trial is studying a medication called abemaciclib to see how well it works for women with a specific type of breast cancer known as triple-negative breast cancer. This trial focuses o...

Recruiting

Phase: PHASE2 Type: interventional Locations: Scottsdale, Arizona, United States, Jacksonville, Florida, United States +1 more

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

NCT ID: NCT05269381

This clinical trial is investigating a new type of personalized vaccine designed to help the immune system recognize and attack advanced solid tumors, which are cancers that have spread beyond thei...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jacksonville, Florida, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions